An announcement from Alcidion Group Limited ( (AU:ALC) ) is now available.
Alcidion Group Limited reported a 7.46% decline in revenue for the half-year ending December 2024, primarily due to the completion of a major project with Leidos Australia. Despite the revenue drop, the company significantly reduced its net loss by 79.50% to $889,000, attributed to a strategic restructuring that lowered employee expenses.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing innovative health informatics solutions. The company focuses on delivering products and services that enhance healthcare delivery through improved data management and clinical decision support systems.
YTD Price Performance: 53.33%
Average Trading Volume: 1,479,364
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$123.6M
Find detailed analytics on ALC stock on TipRanks’ Stock Analysis page.